The relevance of P2Y(12)-receptor gene variation for the outcome of clopidogrel-treated patients undergoing elective coronary stent implantation: a clinical follow-up

Thromb Haemost. 2012 Jan;107(1):189-91. doi: 10.1160/TH11-05-0306. Epub 2011 Dec 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenosine Diphosphate / chemistry
  • Aged
  • Aspirin / pharmacology
  • Clopidogrel
  • Female
  • Follow-Up Studies
  • Genetic Variation*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / genetics
  • Myocardial Infarction / mortality
  • Platelet Aggregation
  • Polymorphism, Single Nucleotide
  • Purinergic P2Y Receptor Antagonists / pharmacology
  • Receptors, Purinergic P2Y12 / chemistry*
  • Software
  • Stents / adverse effects*
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / pharmacology

Substances

  • P2RY12 protein, human
  • Purinergic P2Y Receptor Antagonists
  • Receptors, Purinergic P2Y12
  • Adenosine Diphosphate
  • Clopidogrel
  • Ticlopidine
  • Aspirin